Jump to top menu Jump to main menu Jump to content

News, stories and events (391)

Wanted: test for reliable and rapid diagnosis of frontotemporal dementia

Wanted: test for reliable and rapid diagnosis of frontotemporal dementia

A reliable test that can quickly diagnose frontotemporal dementia. That is the goal of a new project that Erasmus MC neurologist Harro Seelaar and researcher Esther Bron are starting with 15 partners from 9 European countries. The consortium will receive a grant of almost €8 million from the Horizon Europe programme.

Read more
European grants for research into stomach cancer and motor control

European grants for research into stomach cancer and motor control

Neuroscientist Zhenyu Gao and molecular geneticist Miao-Ping Chien from Erasmus MC have been awarded Consolidator Grants from the European Research Council. They will use this 2 million euro grant for research into difficult-to-treat stomach cancer and the brain’s control of movement.

Read more
Encephalitis: longer chance of recovery than thought

Encephalitis: longer chance of recovery than thought

Recovery from a rare anti-NMDAR encephalitis is possible for longer than previously thought. In the first six months, epileptic seizures dissolve and deficits improve the fastest, but improvement is possible up to three years after diagnosis. This is evident from research by Erasmus MC. ‘I believe in growth.’

Read more
Newly discovered protein holds DNA repair complex together

Newly discovered protein holds DNA repair complex together

Scientists have discovered a protein that plays an important role in the repair of DNA damage. Acting like molecular glue, it holds together the crucial parts of the DNA repair complex, ensuring its correct functioning. This is important, as correct DNA repair is crucial to protects cells against aging.

Read more

Success Story: Ansh-labs

Anti-Müllerian Hormone (AMH) assay.

Read more

Success Story: Spatium Medical

Spatium Medical is an innovative spin-off from Erasmus MC in Rotterdam, developing the next generation of insufflation technology.

Read more

Success Story: LentiCure (Spin-off)

LentiCure: Innovation in Gene Therapy for Rare Muscular Diseases. Erasmus MC spin-off company LentiCure develops an advanced and life-saving gene therapy for Pompe disease and bring it to the market at a socially responsible price

Read more

Nominations for Start-Up Competition

We are thrilled to announce that Technology Transfer Office (TTO) – Erasmus MC has nominated two incredible companies for the prestigious Academic Startup Competition 24'25!

Read more

Erasmus MC Projects Selected for the Venture Challenge

Great news from LifeSciences@Work. After the pitch interviews, three highly promising Erasmus MC spin-offs have been selected to join the Venture Challenge program. Over the course of 10 weeks, the teams will work on their business cases, refine their pitches, and develop their entrepreneurial skills. A fantastic opportunity!

Read more

TTO Launches New Website: Enhance the Impact of Your Research

The Technology Transfer Office (TTO) is excited to announce the launch of its newly redesigned website. This updated platform provides useful information about the valorization process, and it offers researchers an opportunity to learn how to create more impact with your research.

Read more
Team seeks solution for ‘fighting the ventilator’

Team seeks solution for ‘fighting the ventilator’

It’s a common situation in intensive care: patients who are “fighting the ventilator”. A team from Erasmus MC and the startup Deep Breath is working with AI-driven software to find a solution for this harmful phenomenon.

Read more
‘If I wake up and say ‘Ajax,’ the surgery has failed’

‘If I wake up and say ‘Ajax,’ the surgery has failed’

Epileptic seizures and a brain hemorrhage caused Tom van Vliet to lose trust in his own body. But after a complex, tense, and successful surgery, he now dares to make plans for his retirement. A procedure he would recommend to anyone. ‘Otherwise, we would still be living in uncertainty.’

Read more